Agatha N. Jassem

2.0k total citations
72 papers, 853 citations indexed

About

Agatha N. Jassem is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Agatha N. Jassem has authored 72 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 35 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in Agatha N. Jassem's work include SARS-CoV-2 and COVID-19 Research (35 papers), Respiratory viral infections research (24 papers) and Influenza Virus Research Studies (20 papers). Agatha N. Jassem is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (35 papers), Respiratory viral infections research (24 papers) and Influenza Virus Research Studies (20 papers). Agatha N. Jassem collaborates with scholars based in Canada, United States and Australia. Agatha N. Jassem's co-authors include Mel Krajden, Danuta M. Skowronski, Hugues Charest, James A. Dickinson, Jonathan B. Gubbay, Gaston De Serres, Natalie Prystajecky, Nathalie Bastien, Steven J. Drews and Suzana Sabaiduc and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Agatha N. Jassem

63 papers receiving 840 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Agatha N. Jassem Canada 18 467 456 98 86 85 72 853
Shannon Emery United States 9 756 1.6× 418 0.9× 39 0.4× 100 1.2× 61 0.7× 13 1.0k
Emilia Lupulescu Romania 12 532 1.1× 243 0.5× 118 1.2× 41 0.5× 66 0.8× 28 711
Janice Lo China 14 548 1.2× 223 0.5× 34 0.3× 135 1.6× 29 0.3× 26 740
Maria Exindari Greece 12 263 0.6× 221 0.5× 25 0.3× 115 1.3× 40 0.5× 42 580
Yu-Chia Hsieh Taiwan 17 539 1.2× 117 0.3× 39 0.4× 68 0.8× 15 0.2× 26 784
А. А. Соминина Russia 9 427 0.9× 208 0.5× 31 0.3× 43 0.5× 58 0.7× 50 572
Ramona Trebbien Denmark 22 795 1.7× 460 1.0× 49 0.5× 125 1.5× 64 0.8× 66 1.1k
Ignacio Torres Spain 16 270 0.6× 646 1.4× 19 0.2× 129 1.5× 74 0.9× 55 938
Gary E. Hollick United States 11 406 0.9× 204 0.4× 37 0.4× 55 0.6× 81 1.0× 31 605
Ravit Bassal Israel 14 238 0.5× 299 0.7× 18 0.2× 29 0.3× 47 0.6× 49 627

Countries citing papers authored by Agatha N. Jassem

Since Specialization
Citations

This map shows the geographic impact of Agatha N. Jassem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agatha N. Jassem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agatha N. Jassem more than expected).

Fields of papers citing papers by Agatha N. Jassem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agatha N. Jassem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agatha N. Jassem. The network helps show where Agatha N. Jassem may publish in the future.

Co-authorship network of co-authors of Agatha N. Jassem

This figure shows the co-authorship network connecting the top 25 collaborators of Agatha N. Jassem. A scholar is included among the top collaborators of Agatha N. Jassem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agatha N. Jassem. Agatha N. Jassem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reicherz, Frederic, Jeffrey N. Bone, A Lavoie, et al.. (2025). Recovery of Antibody Immunity After a Resurgence of Respiratory Syncytial Virus Infections. The Journal of Infectious Diseases. 231(5). e840–e845. 4 indexed citations
2.
Smailus, Duane E., et al.. (2024). Validation of an Automated, End-to-End Metagenomic Sequencing Assay for Agnostic Detection of Respiratory Viruses. The Journal of Infectious Diseases. 230(6). e1245–e1253. 2 indexed citations
3.
Russell, Shannon, Michelle Coombe, James E. A. Zlosnik, et al.. (2024). Descriptive Epidemiology and Phylodynamics of the “First Wave” of an Outbreak of Highly Pathogenic Avian Influenza (H5N1 Clade 2.3.4.4b) in British Columbia and the Yukon, Canada, April to September 2022. Transboundary and Emerging Diseases. 2024(1). 2327939–2327939. 4 indexed citations
4.
Caza, Mélissa, et al.. (2024). Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel for detection of pathogens in nasopharyngeal and lower respiratory tract specimens. Diagnostic Microbiology and Infectious Disease. 110(1). 116368–116368. 2 indexed citations
5.
6.
Prystajecky, Natalie, et al.. (2024). Nasopharyngeal angiotensin converting enzyme 2 (ACE2) expression as a risk-factor for SARS-CoV-2 transmission in concurrent hospital associated outbreaks. BMC Infectious Diseases. 24(1). 262–262. 1 indexed citations
7.
Morshed, Muhammad, et al.. (2023). Clinical utility and interpretive guidance for SARS-CoV-2 serological testing. Clinical Microbiology Newsletter. 45(24). 209–218.
8.
Asamoah-Boaheng, Michael, Brian Grunau, Mohammad Ehsanul Karim, et al.. (2023). Eleven-month SARS-CoV-2 binding antibody decay, and associated factors, among mRNA vaccinees: implications for booster vaccination. Access Microbiology. 5(11). 2 indexed citations
9.
Caya, Chelsea, Matthew P. Cheng, Karen Colwill, et al.. (2023). Two‐phase Bayesian latent class analysis to assess diagnostic test performance in the absence of a gold standard: COVID‐19 serological assays as a proof of concept. Vox Sanguinis. 118(12). 1069–1077. 2 indexed citations
10.
Skowronski, Danuta M., Solmaz Setayeshgar, Macy Zou, et al.. (2022). Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada. The Journal of Infectious Diseases. 226(3). 485–496. 7 indexed citations
11.
Grunau, Brian, Martin A. Prusinkiewicz, Michael Asamoah-Boaheng, et al.. (2022). Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273. Microbiology Spectrum. 10(2). e0270221–e0270221. 3 indexed citations
12.
13.
Gibbs, Ebrima, Ana Márquez, Soren Gantt, et al.. (2021). A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG. Journal of Clinical Virology. 146. 105050–105050. 14 indexed citations
14.
15.
Sherwood, Karen, David D. M. Nicholl, Franz Fenninger, et al.. (2021). Comprehensive Immune Profiling of a Kidney Transplant Recipient With Peri-Operative SARS-CoV-2 Infection: A Case Report. Frontiers in Immunology. 12. 753558–753558. 2 indexed citations
16.
17.
Himsworth, Chelsea G., Jun Duan, Natalie Prystajecky, et al.. (2019). TARGETED RESEQUENCING OF WETLAND SEDIMENT AS A TOOL FOR AVIAN INFLUENZA VIRUS SURVEILLANCE. Journal of Wildlife Diseases. 56(2). 397–397. 15 indexed citations
18.
Li, Lisa, David Puddicombe, Sylvie Champagne, et al.. (2018). HIV serology signal-to-cutoff ratio as a rapid method to predict confirmation of HIV infection. European Journal of Clinical Microbiology & Infectious Diseases. 37(8). 1589–1593. 2 indexed citations
19.
Jassem, Agatha N., Natalie Prystajecky, Fawziah Marra, et al.. (2016). Characterization ofClostridium difficileStrains in British Columbia, Canada: A Shift from NAP1 Majority (2008) to Novel Strain Types (2013) in One Region. Canadian Journal of Infectious Diseases and Medical Microbiology. 2016. 1–8. 7 indexed citations
20.
Jassem, Agatha N., Connor M. Forbes, & David P. Speert. (2014). Investigation of aminoglycoside resistance inducing conditions and a putative AmrAB-OprM efflux system in Burkholderia vietnamiensis. Annals of Clinical Microbiology and Antimicrobials. 13(1). 2–2. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shannon Emery Breakdown of academic impact, for papers by Emilia Lupulescu Breakdown of academic impact, for papers by Janice Lo Breakdown of academic impact, for papers by Maria Exindari Breakdown of academic impact, for papers by Yu-Chia Hsieh Breakdown of academic impact, for papers by А. А. Соминина Breakdown of academic impact, for papers by Ramona Trebbien Breakdown of academic impact, for papers by Ignacio Torres Breakdown of academic impact, for papers by Gary E. Hollick Breakdown of academic impact, for papers by Ravit Bassal
Rankless by CCL
2026